Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Emergent BioSolutions Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 May 2016 Reuters Investment Profile 12 $20.00

Company Snapshot - Emergent Biosolutions Inc

Two Directors at Emergent Biosolutions Inc sold after exercising options/sold 67,626 shares at between 42.326USD and 43.129US...

27 May 2016 Directors Deals Ltd. 1 $12.00

Thomson Reuters Stock Report - Emergent BioSolutions Inc (EBS-N)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for EBS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

22 May 2016 ValuEngine, Inc. 11 $25.00


", the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 May 2016 Pechala's Reports 2 $25.00

Validea Guru Analysis Report for EBS. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

20 May 2016 Validea 0 $12.00

Value Graph: EMERGENT BIO -- EBS

20 May 2016 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of EMERGENT BIOSOLUTIONS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

20 May 2016 Jefferson Research 11 $20.00

Company Snapshot - Erste Group Bank Ag

A director at Erste Group Bank Ag bought 1,000 shares at 23.173EUR and the significance rating of the trade was 52/100. Is t...

16 May 2016 Directors Deals Ltd. 1 $12.00

Laidlaw: Emergent BioSolutions (EBS, Buy, $35 PT) October Contract Likely $1B+ Size, Multi-Year

EBS recently reported a surprisingly profitable 1Q16, handily beating us and consensus on both the top & bottom line. The EPS...

11 May 2016 Laidlaw & Company 9 $25.00